About Moderna
Moderna is a company based in Cambridge (United States) founded in 2010 by Robert S Langer, Kenneth R Chien, and Timothy A Springer. It operates as a HealthTech. Moderna has raised $2.78 billion across 21 funding rounds from investors including Merck, Fidelity Investments and Astrazeneca. The company has 5,800 employees as of December 31, 2024. Moderna has completed 1 acquisition, including OriCiro Genomics. Moderna offers products and services including mRNA Medicines. Moderna operates in a competitive market with competitors including BridgeBio, Adaptive Biotechnologies, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 5800 as on 31 Dec, 2024
- Founders Robert S Langer, Kenneth R Chien, Timothy A Springer
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Moderna, Inc.
-
Annual Revenue
$3.24 B-52.69as on Dec 31, 2024
-
Net Profit
$-3.56 B24.46as on Dec 31, 2024
-
EBITDA
$-3.76 B-3.59as on Dec 31, 2024
-
Total Equity Funding
$2.78 B (USD)
in 21 rounds
-
Latest Funding Round
$590 M (USD), Grant
Jan 17, 2025
-
Investors
Merck
& 21 more
-
Employee Count
5800
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Moderna
Moderna is a publicly listed company on the NASDAQ with ticker symbol MRNA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Moderna
Moderna offers a comprehensive portfolio of products and services, including mRNA Medicines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
mRNA medicines are developed to fight various diseases.
Unlock access to complete
Unlock access to complete
Software Development Team
237 people
Leadership Team
139 people
Senior Team
69 people
Product Management Team
68 people
Operations Team
50 people
Principal Team
36 people
Data Analysis and Operations Team
34 people
Finance and Accounting
21 people
Unlock access to complete
Funding Insights of Moderna
Moderna has successfully raised a total of $2.78B across 21 strategic funding rounds. The most recent funding activity was a Grant round of $590 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Grant — $590.0M
-
First Round
First Round
(27 Nov 2012)
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Grant - Moderna | Valuation | HHS |
|
| Jul, 2024 | Amount | Grant - Moderna | Valuation | HHS |
|
| Oct, 2020 | Amount | Grant - Moderna | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Moderna
Moderna has secured backing from 22 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, Fidelity Investments and Astrazeneca. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in Asia and Europe
|
Founded Year | Domain | Location | |
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Moderna
Moderna has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OriCiro Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Technologies for DNA synthesis and amplification are developed.
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Moderna
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Moderna Comparisons
Competitors of Moderna
Moderna operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Adaptive Biotechnologies, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Moderna
Frequently Asked Questions about Moderna
When was Moderna founded?
Moderna was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is Moderna located?
Moderna is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Moderna a funded company?
Moderna is a funded company, having raised a total of $2.78B across 21 funding rounds to date. The company's 1st funding round was a Grant of $56M, raised on Nov 27, 2012.
How many employees does Moderna have?
As of Dec 31, 2024, the latest employee count at Moderna is 5,800.
What is the annual revenue of Moderna?
Annual revenue of Moderna is $3.24B as on Dec 31, 2024.
What does Moderna do?
Moderna is engaged in pioneering mRNA technology to create medicines that combat diseases by instructing cells to produce necessary proteins. The company operates in the biotechnology sector, targeting a wide range of conditions, including those with no current treatments. Solutions are designed to be accessible, free of animal products or preservatives, and are developed rapidly through a unique platform that allows multiple mRNA designs to be tested efficiently. Efforts are made to deliver impactful health solutions globally.
Who are the top competitors of Moderna?
Moderna's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Moderna offer?
Moderna offers mRNA Medicines.
Is Moderna publicly traded?
Yes, Moderna is publicly traded on NASDAQ under the ticker symbol MRNA.
How many acquisitions has Moderna made?
Moderna has made 1 acquisition, including OriCiro Genomics.
Who are Moderna's investors?
Moderna has 22 investors. Key investors include Merck, Fidelity Investments, Astrazeneca, Alexion, and Julius Baer.
What is Moderna's ticker symbol?
The ticker symbol of Moderna is MRNA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.